Business Standard

Big pharma firms shift tack, look to bet on trade generics as volumes dip

It is the fastest growing segment in IPM with a 25% CAGR

pharma, pharma firm, medicines
Premium

There are over 9,304 Jan Aushadhi stores in the country as of FY23, making it the largest pharmacy chain in India

Sohini Das Mumbai
Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market.

Big companies like Cipla and Alkem have a significant presence in the segment but recently, players like Torrent Pharmaceuticals and Dr Reddy’s Laboratories (DRL) have also entered this market. What is driving big pharma’s focus on trade generics?

The volume growth in the Indian Pharma Market (IPM) has come down from 5.6 per cent in FY16 to 0.1 per cent in FY23. The Centre, too, is focusing on trade generics as it

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 30 2023 | 12:14 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com